XLO
Xilio Therapeutics, Inc. Common Stock
$9.23
0.00%
0.00
Notify me if price changes either direction
Buy XLO stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
60.7M
Enterprise value
-69002184
Trailing PE
-2.1933152284302
Forward PE
-15.913793
PEG Ratio
0.028490486472392
Enterprise to EBITDA
2.298
Enterprise to revenue
-1.077
Price to book MRQ
1.1856133
Price to sales TTM
0.9476192
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
64.1M
EBITDA
-30030000
Diluted EPS TTM
-0.32
Total Cash (MRQ)
136.0M
Current ratio (MRQ)
4.254
Operating Cash Flow (TTM)
-60598000
XLO trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
